Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-003946
Filing Date
2015-11-09
Accepted
2015-11-09 08:01:08
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ocata_10q-093015.htm 10-Q 381227
2 CERTIFICATION ocata_10q-ex3101.htm EX-31.1 7672
3 CERTIFICATION ocata_10q-ex3102.htm EX-31.2 7527
4 CERTIFICATION ocata_10q-ex3201.htm EX-32.1 2996
5 CERTIFICATION ocata_10q-ex3202.htm EX-32.2 2927
  Complete submission text file 0001019687-15-003946.txt   2972071

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ocat-20150930.xml EX-101.INS 499563
7 XBRL SCHEMA FILE ocat-20150930.xsd EX-101.SCH 30594
8 XBRL CALCULATION FILE ocat-20150930_cal.xml EX-101.CAL 50529
9 XBRL DEFINITION FILE ocat-20150930_def.xml EX-101.DEF 133903
10 XBRL LABEL FILE ocat-20150930_lab.xml EX-101.LAB 287999
11 XBRL PRESENTATION FILE ocat-20150930_pre.xml EX-101.PRE 230974
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Filer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36855 | Film No.: 151214033
SIC: 2834 Pharmaceutical Preparations